Maven Brands Inc. (OTCPK: TRLF.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Maven Brands Inc. (OTCPK: TRLF.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.51K.
trading between 0.00 and 0.00.
Tweenvest scores Maven Brands Inc. across four factors: quality 8/100, value 51/100. Its strongest factor is value.
TRLF.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.51K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 24.39
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 35.14M
- Employees
- —
- Next earnings
- —
About Maven Brands Inc.
Founded in 2013 and headquartered in Vernon, Canada, Maven Brands Inc. specializes in the cultivation, processing, and distribution of medical cannabis. The company underwent a rebranding in November 2021, previously operating as True Leaf Brands Inc.
- ISIN
- CA57768L1058
- Founded
- 2013
- Listed since
- Feb 13, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.